Moderna

Moderna Files for FDA Authorization for COVID-19 Vaccine Use in Teens

If cleared by the FDA, Moderna will become the second Covid-19 vaccine available in the U.S. for teens under 18 along with Pfizer-BioNTech's vaccine

NBCUniversal Media, LLC

Moderna on Thursday filed for emergency use authorization from the Food and Drug Administration to use its COVID-19 vaccine in adolescents ages 12 to 17, NBC News reports.

If cleared by the FDA, it will become the second Covid-19 vaccine available in the United States for teens under 18 along with Pfizer-BioNTech's vaccine, which was authorized for adolescents ages 12 to 15 in May.

Moderna said in May that results from its clinical trial among children ages 12 to 17 showed its two-dose mRNA vaccine to be safe and highly effective. The trial included more than 3,700 participants.

Coronavirus Pandemic

Full coverage of the COVID-19 outbreak and how it impacts you

More Evidence Suggests COVID-19 Was in US by Christmas 2019

White House to Host July 4 ‘Independence From Virus' Bash

Moderna's vaccine for adults 18 and older has been administered in the U.S. since December.

Read the full story on NBCNews.com

Contact Us